Venture Capital in Japan – Nippon Medical Research

Nippon Medical Research, Inc. (NMR), is Japanese pharmaceutical venture company funded by japanese venture capital companies. The core business of NMR is the development of a bactericidal antibiotic against MRSA, but in the course of raising equity for its business, NMR has accumulated substantial know-how and contacts in the Japanese public and private venture capital markets, as well as the pharmaceucital industry and public and private research organisations. NMR is now in a position to provide private investment banking services to domestic and foreign pharmaceutical venture companies seeking equity funds from Japan, and/or assisting the location and negotiation of suitable partner(s) for distribution, licence, joint venture etc and for conducting due diligence. © Nippon Medical Research